News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
EvoMax uses experimental data to predict which modifications could improve the tool without having to test thousands of possibilities individually.
This experimental vaccine uses mRNA technology to train immune cells to recognize the parasite that causes cutaneous.
In the field of bioengineering, Penn researchers are leveraging AI to improve gene editing tools and genetic engineering.
John Wherry, PhD, the Richard and Barbara Schiffrin President's Distinguished Professor at Penn Medicine, explains how decades of federal funding for basic science enabled breakthroughs.
The institute will bring together more than 40 partners across academia, industry, government, healthcare, and nonprofit organizations to transform the role of AI in healthcare.
This collaboration, known as Keystone AI + Quantum Factory, will allow institutions to share high-end computing infrastructure and pursue commercial applications for emerging technologies.
The budget includes the Innovate in PA 2.0 Program, which will provide capital for startups, fund clinical trials for life sciences and improve the Commonwealth's innovation network.
The follow-up study of patients ten years later showed promising results.
Learn more about the recipients.
Cherie Kagan, PhD, the Stephen J. Angello Professor of Electrical and Systems Engineering at Penn Engineering, invented small, biodegradable leaf sensors that can measure the health of plants.